Home›People›Tyler Hartmann
Tyler Hartmann

Tyler Hartmann

President at Biolexis Therapeutics.

Executive
Updated Nov 10, 2026·Latest SEC filing Jun 3, 2026·Suggest an edit

About Tyler Hartmann

Tyler Hartmann is a president at Biolexis Therapeutics.

Experience

This experience comes from Tyler Hartmann's profile and from SEC filings. For roles taken from filings, the years are when the filings name Tyler Hartmann in the role, so the role may have started earlier or lasted longer.

Biolexis Therapeutics Inc. Current
President
2026 – Present · Lehi, UT
Develops oral drug candidates for people with obesity and type 2 diabetes.
Clarke Capital Partners Current
Partner
2021 – Present
Clearlink
President
2022 – 2025
EY-Parthenon
Senior Consultant
2017 – 2021
United States Army
Infantry Officer
2010 – 2015

Key Colleagues at Startups

The people Tyler Hartmann works with at each company, as listed on that company's latest Form D.

Biolexis Therapeutics Inc. · Form D, Jun 3, 2026
Hariprasad Vankayalapati
Hariprasad Vankayalapati
Co-founder · Chief Scientific Officer and director
JC
James Clarke
Director
AS
David Bearss
David Bearss
Co-founder · Chairman

Sources

  1. SECBiolexis Therapeutics Inc. Form D, filed Jun 3, 2026